There is renewed interest in neuromodulator/neurotoxins because of 2 newcomers to the US aesthetic market. Jeuveau is FDA approved and Revance will be approved early 2020. To differentiate themselves, these 2 have focused on duration of action of their products. Here’s the lowdown on what patients need to know about these wrinkle eradication injections. […]
Why Dysport is Dr. Weiner’s Favorite Neuromodulator/Neurotoxin
The most popular cosmetic procedure in the world is wrinkle reducing injections with neurotoxins or the friendlier term, neuromodulators. The injections work by reducing the activity of the muscles they are injected to, there by resulting in less movement and less dynamic wrinkles. Static wrinkles, ones that appear at rest, are less affected by these […]
The Top 14 Trends in Cosmetic Procedures (Plastic Surgery) for 2014 as Predicted by Dr. Steven Weiner
This coming year is an exciting one with a couple new FDA approvals expected. It’s also going to see several procedures fade away and new approaches with the “gold standards”. Kythera’s ATX-101 will be approved for reducing the double chin fat using only an injection. The procedure will need to be repeated 3-5 times in […]
What’s new in Botox Treatments, MicroBotox, and the Upcoming “Botox Cream” by Revance Theraputics
Dr. Weiner answers questions about Botox Botox was originally FDA approved for treating stabismus (lazy eye) and blepharospasm (spasms of the eyelids) in 1989. When treating around the eye, patients and doctors were noting the wrinkles around the eyes were improving and brows were elevating. Studies were then initiated by Drs. Jean and Alastair Carruthers […]
